ArticlePloS one2010
FAM-MDR: a flexible family-based multifactor dimensionality reduction technique to detect epistasis using related individuals.
Article in PloS one, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed.
- Dissecting Complex Traits Using Omics Data: A Review on the Linear Mixed Models and Their Application in GWAS.Plants (Basel, Switzerland) · 2022Review
- GADGETS: a genetic algorithm for detecting epistasis using nuclear families.Bioinformatics (Oxford, England) · 2022Article
- Performance of model-based multifactor dimensionality reduction methods for epistasis detection by controlling population structure.BioData mining · 2021Article
- Confounding of linkage disequilibrium patterns in large scale DNA based gene-gene interaction studies.BioData mining · 2019Article
- Fuzzy set-based generalized multifactor dimensionality reduction analysis of gene-gene interactions.BMC medical genomics · 2018Article
- KNN-MDR: a learning approach for improving interactions mapping performances in genome wide association studies.BMC bioinformatics · 2017Article
- An efficient gene-gene interaction test for genome-wide association studies in trio families.Bioinformatics (Oxford, England) · 2016Article
- A roadmap to multifactor dimensionality reduction methods.Briefings in bioinformatics · 2016Review
- Novel Online Dimensionality Reduction Method with Improved Topology Representing and Radial Basis Function Networks.PloS one · 2015Article
- Practical aspects of genome-wide association interaction analysis.Human genetics · 2014Review
- Family studies of type 1 diabetes reveal additive and epistatic effects between MGAT1 and three other polymorphisms.Genes and immunity · 2014Article
- Testing gene-environment interactions in family-based association studies using trait-based ascertained samples.Statistics in medicine · 2014Article
- A robustness study of parametric and non-parametric tests in model-based multifactor dimensionality reduction for epistasis detection.BioData mining · 2013Article
- An efficient algorithm to perform multiple testing in epistasis screening.BMC bioinformatics · 2013Article
- Challenges and opportunities in genome-wide environmental interaction (GWEI) studies.Human genetics · 2012Review
- A family-based association test to detect gene-gene interactions in the presence of linkage.European journal of human genetics : EJHG · 2012Article
- High-throughput analysis of epistasis in genome-wide association studies with BiForce.Bioinformatics (Oxford, England) · 2012Article
- Article
- Multilocus family-based association analysis of seven candidate polymorphisms with essential hypertension in an african-derived semi-isolated brazilian population.International journal of hypertension · 2012Article
- Lower-order effects adjustment in quantitative traits model-based multifactor dimensionality reduction.PloS one · 2012Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We propose a novel multifactor dimensionality reduction method for epistasis detection in small or extended pedigrees, FAM-MDR. It combines features of the Genome-wide Rapid Association using Mixed Model And Regression approach (GRAMMAR) with Model-Based MDR (MB-MDR). We focus on continuous traits, although the method is general and can be used for outcomes of any type, including binary and censored traits. When comparing FAM-MDR with Pedigree-based Generalized MDR (PGMDR), which is a generalization of Multifactor Dimensionality Reduction (MDR) to continuous traits and related individuals, FAM-MDR was found to outperform PGMDR in terms of power, in most of the considered simulated scenarios. Additional simulations revealed that PGMDR does not appropriately deal with multiple testing and consequently gives rise to overly optimistic results. FAM-MDR adequately deals with multiple testing in epistasis screens and is in contrast rather conservative, by construction. Furthermore, simulations show that correcting for lower order (main) effects is of utmost importance when claiming epistasis. As Type 2 Diabetes Mellitus (T2DM) is a complex phenotype likely influenced by gene-gene interactions, we applied FAM-MDR to examine data on glucose area-under-the-curve (GAUC), an endophenotype of T2DM for which multiple independent genetic associations have been observed, in the Amish Family Diabetes Study (AFDS). This application reveals that FAM-MDR makes more efficient use of the available data than PGMDR and can deal with multi-generational pedigrees more easily. In conclusion, we have validated FAM-MDR and compared it to PGMDR, the current state-of-the-art MDR method for family data, using both simulations and a practical dataset. FAM-MDR is found to outperform PGMDR in that it handles the multiple testing issue more correctly, has increased power, and efficiently uses all available information.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.